NVCT   $8.08  -1.70% Market Closed After Close 8.08 0.0

Nuvectis Pharma, Inc.
Total Cash 17.17M
totalCashPerShare 0.904
EBITDA
Total Debt 0.00
quickRatio 2.718
currentRatio 2.74
Total Revenue
debtToEquity
Revenue/Share
ROA -0.60855997
ROE -1.4000101
grossProfits
freeCashflow -10.03M
operatingCashflow -13.63M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 137.56M
forwardPE -7.8365383
floatShares 6.76M
sharesOutstanding 18.65M
sharesShort 1.05M
sharesShortPriorMonth 977.05K
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.53%
heldPercentInstitutions 0.12%
Short Ratio help_outline 11.50%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 0.579
Price To Book help_outline 14.08
earningsQuarterlyGrowth
netIncomeToCommon -19.37M
trailingEps -1.41%
forwardEps -1.04%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.26 4Q 2024
institutionsCount 59
lastUpdated Nov. 7, 2024, 8:57 a.m.